Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 41 to 50 of 107 resources

  • National Clinical Guidelines for the treatment of HCV in adults
    These Scottish guidelines, updated in January 2016, provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness. Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.
    Scotland Jan 2017 Other, Strategy & Planning PDF
  • HCV Action and PHE hepatitis C roadshow in Manchester: Presentations
    On 13th December 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Manchester. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Manchester and the wider north west region.
    UK, England, North West Other, Strategy & Planning PDF
  • Hepatitis C Commissioning Toolkit
    The Hepatitis C Commissioning Toolkit, originally published in September 2013 and most recently updated in September 2018, outlines the importance of effective commissioning in eliminating hepatitis C and sets out key commissioning responsibilities, with the intention of bringing clarity to an often highly fragmented commissioning landscape.
    England Case study, Tools & Templates, Strategy & Planning PDF
  • Working Together to Reduce Harm (Substance Misuse) Delivery Plan 2016 - 2018
    This Welsh Government delivery plan describes the work that will be undertaken reduce the harm caused by substance misuse. It includes actions related to hepatitis C such as the implementation of routine opt-out testing in substance misuse services.
    UK, Wales Sep 2016 Strategy & Planning PDF
  • Hepatitis C among drug users in Europe: Epidemiology, treatment and prevention
    This report, produced by the European Monitoring Centre for Drugs and Drug Addiction, provides an overview of the epidemiology of hepatitis C in Europe. It contains chapters on issues such as providing hepatitis C treatment to people who inject drugs, strategies to improve hepatitis C care and increasing uptake of treatment among people who inject drugs, and hepatitis C prevention among people who inject drugs.
    UK, Rest of World Aug 2016 Reports & Research, Strategy & Planning PDF
  • HCV Action and PHE hepatitis C roadshow in Newcastle: Presentations
    On 17th May 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Newcastle. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Newcastle and the wider north east region.
    North East, UK, England Jun 2016 Other, Strategy & Planning PDF
  • WHO Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection
    These guidelines, developed by the World Health Organisation, promote the transition to newer, more effective medicines that have the potential to cure most persons living with hepatitis C infection. They also provide guidance on which specific regimens should be used based on a patient’s clinical history as well as genotype, and are intended to promote the scale-up of hepatitis C treatment.
    UK, Rest of World Apr 2016 Other, Strategy & Planning PDF
  • Hepatitis C ODNs and Clinical Leads
    Operational Delivery Networks (ODNs) are the new structures through which hepatitis C treatment in England is being delivered. The Network involves regional centres which manage treatment decisions and prescribing, and which have a dispersed treatment model which aims to support partnership working and access for local patients.

    This graphic details each ODN across England, along with the named ODN Clinical Lead for each.
    England Apr 2016 Other, Strategy & Planning PDF
  • Guidance: Hepatitis C prevention, diagnosis and treatment in prisons in England
    This document, published by The Hepatitis C Trust after convening an expert group of prison healthcare commissioners and practitioners, provides commissioners and prison healthcare teams with practical guidance regarding the implementation of opt-out BBV testing and related hepatitis C care pathways, which can be adapted and used by any prison that needs to develop, revise or update their services.

    UK, England Mar 2016 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • The blood borne virus opt-out testing policy for prisons in England: An analysis of need towards full implementation
    In recognition of the exceptionally high prevalence of blood borne viruses (BBVs), in particular hepatitis C, amongst people in prisons and previously very low rates of testing, in October 2013 Public Health England (PHE), NHS England and the National Offender Management Service (NOMS) agreed to introduce opt-out testing for hepatitis B, hepatitis C and HIV across the prison estate by 2016/17.
    UK, England Mar 2016 Reports & Research, Strategy & Planning PDF

Pages